The investment at AstraZeneca's Irish Alexion plants will allow for increased production. Photograph: iStockAstraZeneca has announced further investment at its Irish plants in Blanchardstown and Athlone.
The €65 million investment follows a €341 million investment announced last year for the Blanchardstown facility on a new manufacturing unit on the site.
Excellent news.
Excellent news.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: